Recent investigations in Bengaluru and Delhi have uncovered the alarming distribution of counterfeit medications in various hospitals. These incidents expose serious vulnerabilities in the pharmaceutical supply chain, revealing diverted cancer treatments originating from government hospitals. The issue encompasses more than just manufacturing flaws; it concerns the entire journey of drugs from suppliers to patients. Employing robust technology and verification processes is essential to curtail future instances of fake-drug rackets. Recent investigations in Bengaluru and Delhi have uncovered the alarming distribution of counterfeit medications in various hospitals. These incidents expose serious vulnerabilities in the pharmaceutical supply chain, revealing diverted cancer treatments originating from government hospitals. The issue encompasses more than just manufacturing flaws; it concerns the entire journey of drugs from suppliers to patients. Employing robust technology and verification processes is essential to curtail future instances of fake-drug rackets.
Trending
- ‘Police action delayed’: Gurgaon biker Sia after accused arrested in hit-and-run case
- ‘Political conspiracy’: Sena (UBT) slams CBI for mentioning Thackerays in FIR on Salian case
- Suspected sabotage hits Dutch rail during rush hour; material found on tracks
- Satellites, missiles or something else? US admits it has ‘on-orbit’ weapons for first time
- Texas landowners sue to stop border work through Big Bend under $46bn federal push
- Tendulkar’s ODI record broken: Zimbabwe’s Brendan Taylor makes history
- Fake cancer drugs and ICU injections sold at 50% off, and hospitals bought them
- Four families per floor, no common walls: Urbanest Realty’s Eastfield, Hoskote